» Articles » PMID: 10455004

Recombinant Hyaluronate Associated Protein As a Protective Immunogen Against Streptococcus Equi and Streptococcus Zooepidemicus Challenge in Mice

Overview
Journal Microb Pathog
Date 1999 Aug 24
PMID 10455004
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The capsule of Streptococcus equi, the cause of strangles, and Streptococcus zooepidemicus, associated with equine lower airway disease, plays an important role in evasion of phagocytosis by polymorphonuclear leucocytes. It is composed of hyaluronate, making it non-immunogenic. A hyaluronate associated protein (HAP) from S. equisimilis, whose gene has been sequenced [1], was investigated (a) for its presence in S. equi and S. zooepidemicus and (b) as an immunogen able to interfere with capsule structure and protect against experimental challenge of mice. The purified capsule of S. equi contained a protein of similar molecular mass to the S. equisimilis protein (approximately 53 kDa). Polymerase chain reaction (PCR) using primers derived from the published sequence of S. equisimilis HAP yielded a product from S. equi and S. zooepidemicus of the expected size and susceptibility to restriction endonucleases. Subcloning of two large in frame StuI/SspI fragments of the HAP gene from S. equi, approximately equivalent to the two halves of the molecule, into the expression vector pGEX-3X yielded only the carboxy half in the correct orientation. This latter recombinant produced a GST fusion protein (HAP-GST) of the expected size that was affinity purified. Antibodies in rabbit antiserum to the native protein in purified hyaluronate reacted strongly in immunoblots with HAP-GST. Antiserum to HAP-GST, when soaked into filter paper strips, caused a diminution of capsule production by S. equi cultured on blood agar. Antiserum added into fresh rabbit blood was not opsonic for S. equi. Immunization with HAP-GST significantly reduced rhinitis in Balb/C mice challenged nasally with S. equi and significantly increased survival time and clearance of bacteria in CBA/CA mice challenged intraperitoneally with S. zooepidemicus.

Citing Articles

Genetic basis of murine antibacterial defense to streptococcal lung infection.

Hollingsworth J, Whitehead G, Berman K, Tekippe E, Gilmour M, Larkin J Immunogenetics. 2007; 59(9):713-24.

PMID: 17701033 DOI: 10.1007/s00251-007-0242-6.


Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Hamilton A, Robinson C, Sutcliffe I, Slater J, Maskell D, Davis-Poynter N Infect Immun. 2006; 74(12):6907-19.

PMID: 17015455 PMC: 1698103. DOI: 10.1128/IAI.01116-06.


Identification of a differentially expressed oligopeptide binding protein (OppA2) in Streptococcus uberis by representational difference analysis of cDNA.

Taylor D, Ward P, Rapier C, Leigh J, Bowler L J Bacteriol. 2003; 185(17):5210-9.

PMID: 12923094 PMC: 181005. DOI: 10.1128/JB.185.17.5210-5219.2003.


Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus.

Harrington D, Greated J, Chanter N, Sutcliffe I Infect Immun. 2000; 68(10):6048-51.

PMID: 10992520 PMC: 101572. DOI: 10.1128/IAI.68.10.6048-6051.2000.